Skip to content
banner-group-news-1900x400

Group News

Aspen Joins South Africa in Mourning Dr Sindi Van Zyl

Apr 11, 2021

Aspen joins the country and the medical fraternity in mourning the passing of Dr Sindi van Zyl, a dedicated and significant contributor to our country’s healthcare system. Dr Van Zyl will always be remembered for her ongoing involvement in helping our country in fighting the HIV/AIDS pandemic as a compassionate doctor and, an HIV clinician.…

Read More >>

VIDEOS – Stephen Saad’s address on the occasion of President Cyril Ramaphosa’s visit at our Sterile Facility in the Eastern Cape

Mar 29, 2021

Stephen Saad’s address on the occasion of President Cyril Ramaphosa’s visit at our Sterile Facility in the Eastern Cape at which time he announced the agreement reached with Johnson & Johnson to supply 250 million covid-19 vaccines to Africa, with 30 million being for South Africa

Read More >>

PRESS RELEASE – Aspen welcomes President Ramaphosa and his delegation to Aspen’s world class sterile manufacturing facility

Mar 29, 2021

Gqeberha, South Africa – Aspen, a global multinational specialty pharmaceutical company, earlier today hosted President Cyril Ramaphosa and an accompanying government delegation at its flagship manufacturing site in the Eastern Cape. Aspen has invested in excess of R3.0 billion at this sterile manufacturing site, the single largest investment in the pharmaceutical industry in South Africa. The new…

Read More >>

Stephen Saad, Aspen Chief Executive address to President Ramaphosa and his delegation at Aspen’s flagship manufacturing site in Gqberha, Eastern Cape

Mar 29, 2021

“Our Aspen philosophy has always been to give purpose to life. This is best achieved by contributing meaningfully to others. Aspen has defined itself and continues to define itself as a company that serves humanity, particularly the most vulnerable amongst us. It was over a decade ago that we made a special announcement on a…

Read More >>

Aspen increases revenue by 17% to R18.6 billion

Mar 11, 2021

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced unaudited interim financial results for the six months ended 30 December 2021. Stephen Saad, Aspen Group Chief Executive said, “The business has delivered pleasing results and has proven to be in robust shape over the past six…

Read More >>

Aspen concludes strategic partnership with US-based Avion Pharmaceuticals

Nov 12, 2020

Durban – United States-based Aspen Pharma USA Inc. and Aspen Global Incorporated, located in Mauritius, both wholly owned subsidiaries of Aspen Pharmacare Holdings Limited, have announced a license and commercialisation agreement with Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, for the exclusive rights to relaunch Cenestin® in the USA. This is a New Drug Application…

Read More >>

Aspen announces agreement with Johnson & Johnson to manufacture investigational COVID-19 vaccine candidate

Nov 2, 2020

Durban, South Africa – Aspen is pleased to announce that one of its wholly-owned South African subsidiaries, Pharmacare Limited (which trades as “Aspen Pharmacare”), has entered into a preliminary agreement with Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica NV, two of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the technical transfer and proposed commercial…

Read More >>

Aspen increases revenue by 9% to R38,6 billion

Sep 9, 2020

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has announced reviewed provisional Group financial results for the year ended 30 June 2020. COMMENTARY RESHAPING OF THE GROUP The recently announced agreement to divest the assets related to the commercialisation of Aspen’s Thrombosis business in Europe to Mylan…

Read More >>

Divestment of Aspen’s European Thrombosis Business to Mylan and withdrawal of cautionary

Sep 8, 2020

Johannesburg – Following the release of a cautionary announcement on 24 August 2020, Aspen is pleased to announce that, Aspen Global Incorporated (“AGI”), its wholly owned subsidiary incorporated in Mauritius, has concluded an agreement in terms of which Mylan Ireland Limited (“Mylan”) will acquire the commercialisation rights and related intellectual property relating to Aspen’s Thrombosis…

Read More >>

Aspen scoops prized Adam Smith Treasury Award

Jul 22, 2020

Aspen’s Group Treasury Team was recently recognised when they were awarded the highly acclaimed Adam Smith 2020 Best In Class Treasury Solution In Africa Award.

Read More >>

CONTACT DETAILS

Shauneen Beukes
Group Communications Manager
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com

Scroll To Top